Robert Dreicer, MD
Advertisement
Articles by Robert Dreicer, MD
Advertisement
Latest Updated Articles
Dr. Dreicer on the Clinical Implications of the JAVELIN Bladder 100 Trial in Urothelial CancerPublished: July 28th 2021 | Updated:
Dr. Dreicer on Resistance to Antiandrogen Therapy in Prostate CancerPublished: September 8th 2016 | Updated:
Dr. Dreicer on Combination Trials With Radium-223 in mCRPCPublished: November 12th 2016 | Updated:
Dr. Robert Dreicer on Overcoming Resistance Pathways in mCRPCPublished: November 21st 2016 | Updated:
Dr. Dreicer on Ongoing Trials in Prostate CancerPublished: January 11th 2017 | Updated:
Dr. Dreicer Discusses Challenges of Radium-223 in Prostate CancerPublished: January 18th 2017 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
4
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
5